Viewing Study NCT05394233

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:43 AM
Ignite Modification Date: 2026-01-07 @ 6:49 AM
Study NCT ID: NCT05394233
Status: UNKNOWN
Last Update Posted: 2022-05-27
First Post: 2022-05-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Tislelizumab +Bevacizumab+pc for Untreated EGFR+ and High PD-L1 Non-squamous NSCLC
Sponsor: Sichuan Cancer Hospital and Research Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-squamous Non-small Cell Lung Cancer View
None EGFR Gene Mutation View
Keywords: